𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cyclophosphamide therapy in systemic lupus erythematosus and polymyositis

✍ Scribed by Dr. James F Fries; Gordon C Sharp; Hugh O Mcdevitt; Halsted R Holman

Publisher
John Wiley and Sons
Year
1973
Tongue
English
Weight
758 KB
Volume
16
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Frentizole therapy in systemic lupus ery
Frentizole therapy in systemic lupus erythematosus
✍ Umesh K. Sabharwal; John H. Vaughan; Roy A. Kaplan; Charles A. Robinson; John G. πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 439 KB πŸ‘ 2 views
Risk factors for ovarian failure in pati
Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy
✍ Chi Chiu Mok; Chak Sing Lau; Raymond Woon Sing Wong πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 772 KB

## Objective: To determine the incidence of ovarian failure after cyclophosphamide (cyc) treatment for systemic lupus erythematosus (sle) and to identify the risk factors for this complication. ## Methods: The records of 70 premenopausal female sle patients treated with cyc were reviewed retrospe

Intravenous immunoglobulin therapy in sy
Intravenous immunoglobulin therapy in systemic lupus erythematosus-associated thrombocytopenia
✍ William P. Maier; David S. Gordon; Robert F. Howard; Mansoor N. Saleh; Stephen B πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 673 KB

Seven patients with thrombocytopenia and systemic lupus erythematosus were treated with intravenous (IV) doses of human immunoglobulin to assess clinical response and to examine the mechanism of action of IV immunoglobulin in these patients. Five of 7 patients had a >50% increase in their platelet c